|
Market Closed -
Nasdaq
01:30:00 08/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 16.42 USD | -6.17% |
|
-9.58% | - |
| 21/09 | Attovia Therapeutics, Inc.(NasdaqGM:ATTO) added to S&P TMI Index | CI |
| 16/09 | Attovia Therapeutics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 10:00 AM |
| Market Cap | 80Cr 71Cr 67Cr 60Cr 113.88Cr 7.73TCr 114.78Cr 798.59Cr 312.08Cr 3.93TCr 299.91Cr 293.4Cr 13TCr | P/E 2026 * |
-5.91x | P/E 2027 * | -7.84x |
|---|---|---|---|---|---|
| Enterprise Value | 42Cr 37Cr 35Cr 32Cr 60Cr 4.06TCr 60Cr 419.78Cr 164.04Cr 2.07TCr 157.65Cr 154.23Cr 6.63TCr | EV / Sales 2026 * |
900x | EV / Sales 2027 * | - |
| Free-Float |
91.15% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ATTO | Delayed | |
CBOE
| ATTO | Real-time |
Last Transcript: Attovia Therapeutics, Inc.
| 1 day | -6.17% | ||
| 1 week | -9.58% | ||
| Current month | -4.20% | ||
| 1 month | -35.73% |
| 1 week | 16.33 |  | 18.5 |
| 1 month | 16.33 | | 28 |
| Current year | 16.15 | | 28 |
| 1 year | 16.15 | | 28 |
| 3 years | 16.15 | | 28 |
| 5 years | 16.15 | | 28 |
| 10 years | 16.15 | | 28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hangjun Zhan
CTO | Chief Tech/Sci/R&D Officer | - | 16/12/2022 |
Petter Veiby
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/06/2023 |
Tao Fu
CEO | Chief Executive Officer | 54 | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Aaron Royston
BRD | Director/Board Member | 42 | 01/06/2023 |
Tao Fu
BRD | Director/Board Member | 54 | 01/04/2023 |
James Topper
CHM | Chairman | 64 | 01/06/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 06/08/26 | Goldman Sachs & Co. LLC (Private Banking)
| Conversion | Company | 2,55,62,737 | 59.4081% | |
| 06/08/26 | Conversion | 18,65,710 | 4.3359% | |||
| 06/08/26 | Deep Track Capital LP
| Conversion | Company | 2,01,38,956 | 46.8032% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.17% | -9.58% | - | - | 80Cr | |
| +4.16% | +4.16% | +49.37% | +94.17% | 7.47TCr | |
| +0.46% | -1.16% | +23.36% | +79.34% | 5.88TCr | |
| +0.17% | -1.16% | +3.59% | +34.55% | 4.84TCr | |
| +0.50% | -1.77% | +331.24% | +702.20% | 4.28TCr | |
| -0.72% | -4.04% | +25.90% | +29.94% | 4.28TCr | |
| +0.34% | -0.34% | +5.66% | +109.35% | 4.12TCr | |
| -0.11% | +1.96% | +9.19% | +52.66% | 3.11TCr | |
| -2.07% | +1.16% | +35.00% | +26.28% | 3.03TCr | |
| -0.50% | -3.37% | -9.42% | -14.35% | 2.4TCr | |
| Average | -0.40% | -0.59% | +52.65% | +123.79% | 3.95TCr | |
| Weighted average by Cap. | +0.67% | -0.55% | +55.51% | +130.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5L 4L 4L 4L 7L 4.52Cr 7L 46.65L 18.23L 2.3Cr 17.52L 17.14L 7.37Cr | - |
| Net income | -8.34Cr -7.45Cr -6.95Cr -6.31Cr -12Cr -807.38Cr -12Cr -83Cr -33Cr -410.46Cr -31Cr -31Cr -1.32TCr | -11Cr -9.57Cr -8.92Cr -8.11Cr -15Cr -1.04TCr -15Cr -107.1Cr -42Cr -527.06Cr -40Cr -39Cr -1.69TCr |
| Net Debt | -38Cr -34Cr -32Cr -29Cr -54Cr -3.67TCr -54Cr -378.81Cr -148.04Cr -1.86TCr -142.26Cr -139.18Cr -5.99TCr | -29Cr -26Cr -24Cr -22Cr -41Cr -2.77TCr -41Cr -285.99Cr -111.76Cr -1.41TCr -107.4Cr -105.07Cr -4.52TCr |
Employees
44
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/26/07 | $16.42 | -6.17% | 5,15,640 |
| 06/26/06 | $17.50 | -2.75% | 5,21,652 |
| 05/26/05 | $18.00 | +4.80% | 4,55,958 |
| 02/26/02 | $17.17 | -3.49% | 3,48,657 |
| 01/26/01 | $17.79 | +3.79% | 5,30,815 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
16.42USD
Average target price
42.20USD
Spread / Average Target
+157.00%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATTO Stock
Select your edition
All financial news and data tailored to specific country editions
